Comorbidity
Natalie Hellman, Ph.D. (she/her/hers)
Postdoctoral Fellow
Emory University School of Medicine
Atlanta, Georgia, United States
Emily Weiss, Ph.D. (she/her/hers)
Postdoctoral Fellow
Yale University School of Medicine
West Haven, Connecticut, United States
jonathan Bittner, M.S. (he/him/his)
Immaculata University
Harleysville, Pennsylvania, United States
Jennifer Pierce, Ph.D. (she/her/hers)
University of Michigan
Ann Arbor, Michigan, United States
Margaret Davis, Ph.D. (she/her/hers)
Assistant Professor
Yale University School of Medicine
New Haven, Connecticut, United States
Miranda Schaffer, B.A. (she/her/hers)
Doctoral Student
Eastern Michigan University
ANN ARBOR, Michigan, United States
Hallie Tankha, Ph.D. (she/her/hers)
Cleveland Clinic
Cleveland, Ohio, United States
Pain is the most common cause of disability, affecting more than 30% of the world's population (Cohen et al., 2021). Critically, in the United States, the prevalence of chronic pain is higher than heart disease, diabetes, and cancer combined (National Institutes of Health, 2007). Unfortunately, little is known about this disability’s impact on the etiology and maintenance of psychiatric conditions. PTSD (Sigeland et al., 2017) and Borderline Personality Disorder (BPD; Biskin et al., 2014) are shown to have alarmingly high rates of chronic pain and demonstrate a severe need for further research. Indeed, research shows there are differences in the pain experience for individuals with trauma and borderline personality disorder features (Nanavaty et al., 2023) and this impacts treatment outcomes. Current literature suggests that pain severity significantly lowers treatment response rates, in both the leading PTSD treatments (e.g., Prolonged Exposure and Sertraline; Rauch et al., 2021) and BPD treatment (e.g., Dialectical Behavioral Therapy; Herzog et al., 2020). Thus, there is a significant need to elucidate the impact of pain as a disability on the etiology and maintenance of these psychiatric conditions to improve the quality of life and treatment outcomes for this often-underserved population. The current symposium combines the neuroscientific underpinnings of this complex clinical picture with cutting-edge clinical findings framed by a discussant with lived experience. The symposium will begin by discussing the underlying neurobiology of PTSD, BPD, and chronic pain by presenting patient laboratory data and delineating pain-related processes. This first presentation will discuss data from 94 patients with and without chronic pain and detail psychophysiological pain processing profiles. The second presentation will discuss PET findings exploring the kappa opioid receptors as a promising transdiagnostic treatment target for individuals with chronic pain and trauma-related psychopathology. The remaining talks will then focus on these patients' clinical needs, detailing important aspects of their presenting issues and treatment preferences. The third presentation will discuss data from 82 Veterans seeing trauma-focused treatment and how somatic concerns such as pain impact their posttraumatic stress cognitions. Then, based on data collected from over 700 patients, the fourth presentation will present the unique treatment interests and provide recommendations for clinical intervention strategies. Finally, our lived experience discussant will reflect on these findings and speak as both a patient and provider. Together, this set of presentations from diverse speakers aims to further appreciate the impact of a widespread disability (chronic pain) on the struggles and resilience of patients with traumatic stress and BPD disorder symptoms.
Speaker: Jennifer Pierce, Ph.D. (she/her/hers) – University of Michigan
Co-author: Afton Hassett, Psy.D. (she/her/hers) – University of Michigan
Co-author: Steven Harte, Ph.D. (he/him/his) – University of Michigan
Co-author: Guohao Zhu, Ph.D. (he/him/his) – University Of Michigan
Speaker: Margaret T. Davis, Ph.D. (she/her/hers) – Yale University School of Medicine
Co-author: Emily R. Weiss, Ph.D. (she/her/hers) – Yale University School of Medicine
Co-author: Natalie Hellman, Ph.D. (she/her/hers) – Emory University School of Medicine
Co-author: Sylvia Malcore, Ph.D. (she/her/hers) – Ferris state University
Co-author: Ansel Hillmer, Ph.D. – Yale University School of Medicine
Co-author: Ashley Wagner, B.S. – Yale University School of Medicine
Co-author: David Matuskey, M.D. – Yale University School of Medicine
Co-author: Irina Esterlis, Ph.D. – Yale University School of Medicine
Speaker: Miranda R. Schaffer, B.A. (she/her/hers) – Eastern Michigan University
Co-author: Natalie Hellman, Ph.D. (she/her/hers) – Emory University School of Medicine
Co-author: Elizabeth Imbesi, ABPP, Ph.D. – Ann Arbor Veterans Healthcare System
Co-author: Sylvia Malcore, Ph.D. (she/her/hers) – Ferris state University
Co-author: Jessica Ellem, Ph.D. – Ann Arbor Veterans Healthcare System
Co-author: Sheila Rauch, Ph.D, ABPP (she/her/hers) – Atlanta VA Medical Center
Co-author: Chelsea Cawood, Ph.D. (she/her/hers) – Ann Arbor Veterans Healthcare Administration
Co-author: Margaret T. Davis, Ph.D. (she/her/hers) – Yale University School of Medicine
Co-author: Minden Sexton, Ph.D. (she/her/hers) – Ann Arbor Veterans Healthcare Administration
Speaker: Hallie Tankha, Ph.D. (she/her/hers) – Cleveland Clinic
Co-author: Jolin Yamin, PhD (she/her/hers) – Brigham and Women’s Hospital, Harvard Medical School
Co-author: Amanda Shallcross, ND, MPH (she/her/hers) – Cleveland Clinic